Robert W. Hesslein

Companies

• Alnylam PharmaceuticalsGeneral counsel Oct 3, 2024 to Mar 5, 2025¹
• Voyager Therapeutics (United States)General counsel Apr 3, 2019 to Mar 22, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY8,002 shares³$1.9M at $231.83Mar 3, 2025
• Voyager Therapeutics (United States) VYGR102,200 shares⁴$209.5K at $2.05Mar 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 3, 2025Granted 757 shares of Alnylam Pharmaceuticals³
• Oct 1, 2024Granted 7,245 shares of Alnylam Pharmaceuticals⁵
• Mar 20, 2023Sold 4,410 shares at $7.76 of Voyager Therapeutics (United States)⁴
• Feb 17, 2023Sold 3,297 shares at $7.45 of Voyager Therapeutics (United States)⁶
• Feb 13, 2023Sold 2,868 shares at $7.67 of Voyager Therapeutics (United States)⁷
• Jan 17, 2023Sold 792 shares at $10.34 of Voyager Therapeutics (United States)⁸
• Jan 17, 2023Sold 1,396 shares at $9.57 of Voyager Therapeutics (United States)⁸
• Apr 4, 2022Sold 2,786 shares at $8.25 of Voyager Therapeutics (United States)⁹
• Mar 21, 2022Sold 58 shares at $8.68 of Voyager Therapeutics (United States)¹⁰
• Mar 21, 2022Sold 4,897 shares at $8.29 of Voyager Therapeutics (United States)¹⁰
• Feb 17, 2022Sold 4,100 shares at $3.55 of Voyager Therapeutics (United States)¹¹
• Feb 11, 2022Sold 3,252 shares at $3.36 of Voyager Therapeutics (United States)¹²
• Jan 13, 2022Granted 20,000 shares of Voyager Therapeutics (United States)¹³